Synthesis, Characterization and In Vitro & In Silico Biological Evaluation of New Mannich-Based Rhodanine and Thiazolidine-2,4-Dione Derivatives as Potential Anti-Lung Cancer Agents
   
Yazarlar (8)
Şeyma Ateşoğlu Bezm-İ Âlem Vakıf Üniversitesi, Türkiye
Furkan Çakır Bezm-İ Âlem Vakıf Üniversitesi, Türkiye
Ayşe Merve Şenol Sağlık Bilimleri Üniversitesi, Türkiye
Halil Şenol Bezm-İ Âlem Vakıf Üniversitesi, Türkiye
Doç. Dr. Feyzi Sinan TOKALI Kafkas Üniversitesi, Türkiye
Fahri Akbaş Bezm-İ Âlem Vakıf Üniversitesi, Türkiye
Doç. Dr. Erbay KALAY Kafkas Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı SYNLETT (Q3)
Dergi ISSN 0936-5214 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 10-2025
Cilt / Sayı / Sayfa 36 / 17 / 2939–2947 DOI 10.1055/a-2541-1072
Makale Linki https://doi.org/10.1055/a-2541-1072
Özet
AbstractIn this study, 10 new rhodanine and thiazolidine-2,4-dione derivatives based on Mannich-modified vanillin were synthesized, characterized, and evaluated for their anticancer potential against A549 lung cancer and BEAS-2B normal cells. Among them, compound 5c exhibited the most potent anticancer activity, with an IC50 of 2.43 μM and a selectivity index of 10.91, showing higher selectivity than the reference drug sorafenib. Molecular docking studies suggested 5c as a strong potential epidermal growth factor receptor (EGFR) inhibitor, supported by a docking score of –9.827 kcal/mol and key interactions with residues such as Met-793, Leu-788, and Phe-856. Molecular dynamics simulations further confirmed the stability of the 5c-EGFR complex. ADMET predictions indicated favorable pharmacokinetic and safety profiles for 5c, including high permeability, oral absorption, and no significant toxicity. These findings highlight 5c as a promising lead compound for targeted lung cancer therapy, warranting further preclinical studies.
Anahtar Kelimeler
Mannich base | rhodanine | thiazolidine-2,4-dione | molecular docking | A549